9th July, 2025 🔍 Introduction In a significant move toward the digitization of drug regulatory processes in India, the Central Drugs Standard Control Organization (CDSCO), in collaboration with the Centre for Development of Advanced Computing (CDAC), has introduced a major…
8th June 2025, During the 66th meeting of the Drugs Consultative Committee (DCC) held at CDSCO, New Delhi, a significant regulatory concern regarding the unauthorized issuance of manufacturing licenses for new drugs by certain State Licensing Authorities (SLAs) was deliberated. ⚠️…
- vaayath vaayath
- one Comment.
- Pharma News
Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…
Published On: 11th April, 2025 In a decisive move aimed at promoting manufacturing and sale of medical devices for domestic and export market, the Central Drugs Standard Control Organization (CDSCO) has announced a significant upgrade in its online licensing system.…
5th March, 2025 The Ministry of Health and Family Welfare, Government of India, has taken a significant step to streamline and enhance the registration process for Clinical Research Organizations (CRO) by mandating online registration through the SUGAM portal. This initiative,…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
